The most common adverse events in drisapersen-treated patients were injection-site reactions ( @ patients given continuous drisapersen , @ patients given intermittent drisapersen , and six given placebo ) and renal events ( @ for continuous drisapersen , @ for intermittent drisapersen , and seven for placebo ) , most of which were subclinical proteinuria .